Cytokinetics (CYTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CYTK | HALO | AXSM | ||
| Company | Cytokinetics | Halozyme Therapeutic | Axsome Thera | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 64.14 | 68.31 | 153.76 | ||
| High | 64.17 | 68.95 | 154.22 | ||
| Low | 62.72 | 67.95 | 151.27 | ||
| Latest | 63.11 | 68.87 | 152.05 | ||
| Change | -1.07 | +0.46 | -1.59 | ||
| % Change | -1.67% | +0.67% | -1.03% | ||
| Volume | 1,385,300 | 614,900 | 463,100 | ||
| 20-Day Average Volume | 2,038,010 | 2,257,695 | 469,920 | ||
| Previous Close | 64.18 | 68.41 | 153.64 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 63.49 | 65.42 | 149.10 | ||
| 20-Day Raw Stochastic | 32.21% | 66.19% | 61.39% | ||
| 20-Day Relative Strength | 51.11 | 55.19 | 59.57 | ||
| Weighted Alpha | +19.09 | +38.26 | +73.44 | ||
| Today's Opinion | 72% Buy | 32% Buy | 100% Buy | ||
| Previous Opinion | 88% Buy | 24% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.46% since 12/18/25 | +5.77% since 12/18/25 | +3.44% since 12/18/25 | ||
| Low | 62.00 on 12/23/25 | 65.11 on 12/19/25 | 147.18 on 12/19/25 | ||
| High | 70.98 on 12/22/25 | 69.28 on 12/22/25 | 158.56 on 12/23/25 | ||
| 1-Month | |||||
| %Chg | -7.40% since 11/26/25 | -5.22% since 11/26/25 | +0.71% since 11/26/25 | ||
| Low | 59.37 on 12/17/25 | 61.22 on 12/11/25 | 141.69 on 12/02/25 | ||
| High | 70.98 on 12/22/25 | 72.78 on 11/28/25 | 158.56 on 12/23/25 | ||
| 3-Month | |||||
| %Chg | +25.22% since 09/26/25 | -6.62% since 09/26/25 | +30.22% since 09/26/25 | ||
| Low | 50.15 on 09/29/25 | 61.22 on 12/11/25 | 116.18 on 09/29/25 | ||
| High | 70.98 on 12/22/25 | 76.30 on 10/01/25 | 158.56 on 12/23/25 | ||
| 6-Month | |||||
| %Chg | +86.11% since 06/26/25 | +31.11% since 06/26/25 | +48.24% since 06/26/25 | ||
| Low | 32.66 on 07/01/25 | 51.06 on 06/30/25 | 96.09 on 08/04/25 | ||
| High | 70.98 on 12/22/25 | 79.50 on 09/23/25 | 158.56 on 12/23/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,716,144 | 8,098,906 | 7,665,296 | ||
| Shares Outstanding, K | 122,265 | 117,597 | 50,413 | ||
| Annual Sales | 18,470,000 | 1,015,320,000 | 385,690,000 | ||
| Annual Net Income | -589,530,000 | 444,090,000 | -287,220,000 | ||
| Last Quarter Sales | 1,940,000 | 354,260,000 | 170,990,000 | ||
| Last Quarter Net Income | -306,180,000 | 175,230,000 | -47,230,000 | ||
| 60-Month Beta | 0.58 | 0.95 | 0.48 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.54 on 11/05/25 | 1.72 on 11/03/25 | -0.94 on 11/03/25 | ||
| Latest Earnings Date | 02/26/26 | 02/17/26 | 02/17/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 12.86 | 0.00 | ||